Alterity Therapeutics (ATHE) Accumulated Expenses (2021 - 2025)

Alterity Therapeutics' Accumulated Expenses history runs 5 years deep, the most recent figure standing at $1.1 million for Q2 2025.

• In Q2 2025, Accumulated Expenses rose 885.89% year-over-year to $1.1 million; the TTM figure through Jun 2025 stood at $1.1 million (up 885.89% YoY), while the FY2025 annual figure was $1.1 million, down 69.17% from the prior year.
• Accumulated Expenses was $1.1 million for Q2 2025 at Alterity Therapeutics, up from $109439.6 in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $1.5 million in Q2 2022 to a low of $109439.6 in Q2 2024.
• Historically, Accumulated Expenses has averaged $838716.0 across 5 years, with a median of $974676.7 in 2023.
• The sharpest annual moves came in 2024 and 2025: Accumulated Expenses sank 88.77% in 2024, then jumped 885.89% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $550340.7 in 2021, then soared by 168.95% to $1.5 million in 2022, then tumbled by 34.15% to $974676.7 in 2023, then tumbled by 88.77% to $109439.6 in 2024, then surged by 885.89% to $1.1 million in 2025.
• The last three Accumulated Expenses figures came in at $1.1 million (Q2 2025), $109439.6 (Q2 2024), and $974676.7 (Q2 2023), per Business Quant data.